Developing new methods for creating drugs using light-driven chemical reactions
Official title: Bioinspired selective heterogeneous organic photoredox catalysis
Funded at Southern Illinois University Carbondale · NIH-11036485 · Data updated 2026-11-12
This study is exploring a new way to make medicines using light to help create better and safer drugs for patients, making it easier to produce the complex compounds needed for effective treatments.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Southern Illinois University Carbondale NIH-funded |
| Lab location | 1 site (Carbondale, United States) |
| Project start | September 15, 2022 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $100,000 |
| NIH project number | 3R15GM148938-01S1 |
| Project ID | NIH-11036485 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who may benefit from new drug therapies, particularly those with conditions that current medications do not adequately address.
✕Less likely to help
Patients who are not seeking new drug therapies or who have conditions that are already well-managed by existing medications may not receive benefit from this research.
What this research studies
This research focuses on innovative chemical reactions that utilize light to create new drugs, specifically through a process called photoredox catalysis. By employing unique materials known as porous crystalline molecular frameworks, the project aims to overcome challenges in drug synthesis related to efficiency and selectivity. The approach seeks to enhance the way chemical reactions occur at a molecular level, making it easier to produce complex drug compounds that are essential for medical treatments. Patients may benefit from the development of new medications that are more effective and have fewer side effects.
Why it matters
Potential benefit: If successful, this research could lead to the discovery of new drugs that are more effective and easier to produce.
How similar studies have gone: While photoredox catalysis is a growing field, this specific approach using porous crystalline frameworks is relatively novel and has not been extensively tested in prior research.
Where this research is happening
-
Southern Illinois University Carbondale
Carbondale, United States Active
Researchers
- Principal investigator: Deria, Pravas — Southern Illinois University Carbondale
- Study coordinator: Deria, Pravas
Related research
Other NIH-funded projects on the same topics.
-
Rapid pathogen ID and antibiotic testing for bacteremia using immune capture, microfluidics, and AI
A fast, AI-assisted diagnostic system will identify bacteria in blood and determine which antibiotics are likely to work, helping doctors treat bacteremia sooner.
-
Electrografted-MoS2 Immunosensor for Biomarker Detection
A university-led project is developing a robust, covalently linked antibody–MoS2 biosensor to detect biomedical markers.
-
Super-Resolution Confocal Microscope for SIU researchers
A new high-resolution confocal microscope will be purchased for Southern Illinois University, enabling researchers from multiple fields to generate clearer 3D images and advance biomedical work.
-
How social choices shape when to stay with a friend vs. seek food in mice
A study in mice will look at how the brain decides whether to stay with a social partner or pursue food when both options are available.
-
High-speed cell sorting technology for cancer and infectious disease research
A fast, multi-marker cell sorter is being purchased to help SIUC researchers study cancer, immune responses, and infections, plus train students in this cutting-edge technique.
-
How early life stress affects aggression through brain circuitry
This study is looking at how tough experiences in childhood, like feeling alone or going through trauma, can affect the brain and lead to aggressive behavior in adults, with the hope of finding better ways to help people manage their anger.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.